Drug Information

Drug General Information
Drug ID
D00YHI
Former ID
DNC013496
Drug Name
N-(14-methylallyl)norgalanthamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529384]
Formula
C20H25NO3
Canonical SMILES
CC(=C)CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
InChI
1S/C20H25NO3/c1-13(2)11-21-9-8-20-7-6-15(22)10-17(20)24-19-16(23-3)5-4-14(12-21)18(19)20/h4-7,15,17,22H,1,8-12H2,2-3H3/t15-,17-,20-/m0/s1
InChIKey
FEKQBPRIVQKBRM-KNBMTAEXSA-N
PubChem Compound ID
24863955
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [529384]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 529384Bioorg Med Chem Lett. 2008 Apr 1;18(7):2263-6. Epub 2008 Mar 7.N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum.
Ref 529384Bioorg Med Chem Lett. 2008 Apr 1;18(7):2263-6. Epub 2008 Mar 7.N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.